Discuss Drug Payment System of National Health Insurance on the Issue of Prozac
In 2019, National Health Insurance (NHI) adjusted drug price, and may cause brand drugs such as Prozac to withdraw from the Taiwan market. Many physicians are initiative to review policy of drug price adjustment. On the basic guarantee principle of NHI, if the drugs produced from different pharmaceutical companies affirmed by the government with the same efficacy and safety, NHI will choose to pay a low-priced generic drug. It will be appropriate. Besides, patient allows to choose other drugs with deductible. Drug payment policy of NHI should pay the necessary, or hard to replace and expensive drugs. Most people are affordable low-cost drugs, and consider risk retention for the insured. This paper suggests that NHI adopt the drug deductible payment if drug price exceed, the insured should pay certain percentage of the price. The deductible payments with copayment and coinsurance meet the spirit of insurance and the distribution of justice.